Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HB eAg‐positive high viral load chronic hepatitis B

2018 ◽  
Vol 25 (5) ◽  
pp. 552-560 ◽  
Author(s):  
J. Y. Nam ◽  
Y. Chang ◽  
H. Cho ◽  
S. H. Kang ◽  
Y. Y. Cho ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Chronic Hepatitis B ◽  
Viral Suppression ◽  
High Viral Load

Sa1494 - Impact of Antiviral Therapy on Chronic Hepatitis B Patients who had High Viral Load, Persistently Normal Alt, and Mild Liver Fibrosis

2018 ◽  
Vol 154 (6) ◽  
pp. S-1132
Author(s):  
Choochai Teerawattananon ◽  
Supot Nimanong ◽  
Siwaporn P. Chainuvati ◽  
Phunchai Charatcharoenwitthaya ◽  
Tawesak Tanwandee ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Liver Fibrosis ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Chronic Hepatitis B ◽  
High Viral Load ◽  
Normal Alt

Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy

2009 ◽  
Vol 29 (5) ◽  
pp. 775-776
Author(s):  
Rami Moucari ◽  
Claire Francoz ◽  
Olivier Lada ◽  
Wael Abdel Razek ◽  
Patrick Marcellin ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Chronic Hepatitis B ◽  
High Viral Load

Update in management of hepatitis B in pregnancy and prevention of mother to child hepatitis B transmission

2018 ◽  
Vol 1 (3) ◽  
pp. 1-8
Author(s):  
Naichaya Chamroonkul
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
High Viral Load ◽  
World Population ◽  
Hepatitis B Infection ◽  
Mother To Child Transmission ◽  
Child Transmission ◽  
Mother To Child

Even with two decades of widespread using hepatitis B vaccination, chronic hepatitis B remains a major global health problem. In Thailand, the prevalence of chronic hepatitis B infection was down from 8 - 10% in last decade to 5% recently. Failure to control mother to child transmission is one of the important barriers to the total elimination of hepatitis B infection from world population. In the majority, vertical transmission can be prevented with a universal screening program, immunoprophylaxis by administration of hepatitis B vaccine and hepatitis B immunoglobulin (HBIg) for babies born to mothers with HBV. However, in mothers with a high viral load, the chance of immunoprophylaxis failure remains high. To date, there are standard recommendations by all international liver societies including AASLD, EASL and APASL suggest introducing an antiviral agent during the third trimester to CHB pregnant women with a high viral load. Previous US FDA pregnancy category B agents such as Tenofovir and Telbivudine are allowed through all trimesters of pregnancy and are effective for prevention of mother to child transmission. Breastfeeding for patients who receive antiviral agents can be allowed after a risk-benefit discussion with the patient and family.

Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B Patients With High Viral Load and/or High Fibrosis Scores at Week 48 of Therapy

2011 ◽  
Vol 140 (5) ◽  
pp. S-930-S-931 ◽  
Author(s):  
Ayse O. Kurdas Ovunc ◽  
Fatih Guzelbulut ◽  
Ebubekir Senates ◽  
Yasemin Gökden ◽  
Ayca G. Degirmenci Salturk ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
High Viral Load

Five-Year Outcome of Telbivudine versus Entecavir in Treating High Viral Load Chronic Hepatitis B Patients

2016 ◽  
Vol 64 (2) ◽  
pp. S590-S591
Author(s):  
H.-Y. Pan ◽  
Z.-Z. Ren ◽  
H.-J. Huang ◽  
H. Zou ◽  
Y.-X. Tong ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
High Viral Load
Sign in / Sign up

Export Citation Format

Share Document